233 related articles for article (PubMed ID: 24038216)
1. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
[TBL] [Abstract][Full Text] [Related]
2. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.
Federzoni EA; Valk PJ; Torbett BE; Haferlach T; Löwenberg B; Fey MF; Tschan MP
Blood; 2012 May; 119(21):4963-70. PubMed ID: 22498738
[TBL] [Abstract][Full Text] [Related]
3. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.
Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F
Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703
[TBL] [Abstract][Full Text] [Related]
4. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
[TBL] [Abstract][Full Text] [Related]
5. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
[TBL] [Abstract][Full Text] [Related]
6. PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation.
Wei S; Zhao M; Wang X; Li Y; Wang K
J Hematol Oncol; 2016 May; 9(1):44. PubMed ID: 27146823
[TBL] [Abstract][Full Text] [Related]
7. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
8. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
[TBL] [Abstract][Full Text] [Related]
9. Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL.
Humbert M; Federzoni EA; Tschan MP
J Leukoc Biol; 2017 Dec; 102(6):1357-1370. PubMed ID: 28978663
[TBL] [Abstract][Full Text] [Related]
10. A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
Song G; Shi L; Guo Y; Yu L; Wang L; Zhang X; Li L; Han Y; Ren X; Guo Q; Bi K; Jiang G
Oncotarget; 2016 Jan; 7(3):3144-57. PubMed ID: 26673819
[TBL] [Abstract][Full Text] [Related]
11. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
12. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
[TBL] [Abstract][Full Text] [Related]
13. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
Duprez E; Wagner K; Koch H; Tenen DG
EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
[TBL] [Abstract][Full Text] [Related]
14. RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.
Girard N; Tremblay M; Humbert M; Grondin B; Haman A; Labrecque J; Chen B; Chen Z; Chen SJ; Hoang T
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13522-7. PubMed ID: 23898169
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
[TBL] [Abstract][Full Text] [Related]
16. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
[TBL] [Abstract][Full Text] [Related]
18. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
19. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
20. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]